Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?

Recent changes in lung cancer care, including new approvals in first line and the introduction of high-throughput molecular technologies in routine testing led us to question ourselves on how deeper molecular testing may be helpful for the optimal use of targeted drugs. In this article, we review re...

Descripción completa

Detalles Bibliográficos
Autores principales: Garinet, Simon, Laurent-Puig, Pierre, Blons, Hélène, Oudart, Jean-Baptiste
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024886/
https://www.ncbi.nlm.nih.gov/pubmed/29890761
http://dx.doi.org/10.3390/jcm7060144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024886/
https://www.ncbi.nlm.nih.gov/pubmed/29890761
http://dx.doi.org/10.3390/jcm7060144

Ejemplares similares